Searched for
BIOTECH SUPPLY CHAINS
Indian cancer patients battle shortage of key drugs as platinum costs surgeCancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues a...- Kiran Mazumdar-Shaw's Immuneel Therapeutics raises Rs 100 crore from Singularity AMC, Rainmatter, othersThe Bengaluru-based company makes CAR-T therapy, a form of cancer treatment where a patient’s own immune cells are taken out, trained in a ...
- Govt sets up six sector groups to fast-track ‘Make in India 2.0’ pushIn a bold move towards self-sufficiency, India is ramping up its domestic manufacturing initiatives! Six government-led teams are tasked wi...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- US CEOs seek China business gains from Trump-Xi summitAmerican business leaders are heading to China for a summit with President Xi Jinping. They aim to resolve ongoing business challenges and ...
- ET Most Innovative AI Product Awards 2026: Honouring AI Innovations reshaping Life Sciences & Pharma ResearchThe Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...
- Two separate venues for pharma industry expos in Delhi-NCRCPHI India and PMEC India are expanding their pharmaceutical expos to two venues in Delhi-NCR. This move aims to support the rapid growth o...
- US stock market futures today: Why are Dow Jones and S&P 500 in red while Nasdaq turns green today? Dow drops 280 points as oil tops $120— can AI spending offset rising inflation fears and Fed uncertainty?Why are Dow Jones and S&P 500 in red while Nasdaq turns green today? The US stock market futures today are sending a sharp, layered signal....
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- US stock market crashes today: why Dow Jones, S&P 500 and Nasdaq are down? Wall Street turns red as gold and silver prices also slipUS stock market crashes today: why Dow Jones, S&P 500 and Nasdaq are down today? Wall Street turns red as gold and silver prices also slip....
- What is shelf-stable synthetic blood? The scientific advancement that could transform battlefield and emergency careA revolutionary synthetic blood is nearing human trials. This freeze-dried product can be stored for years at room temperature. It can be r...
- Inside China’s ‘Magic’ factories: The tech playbook India can’t ignoreChina's state-of-the-art factories reflect its commitment to innovation, backed by robust research and development initiatives. This enviro...
- India explores FTA full use with Norway, sets up fast-track investment system with AustriaIndia and Norway are enhancing cooperation in energy, maritime, and biotech sectors. Norway sees growing investment interest in India. Mean...
- AgriTech could add $90 billion to Southeast Asia’s GDP by 2033: ReportWhile investments have seen a recent decline due to structural challenges, opportunities abound in digital value chains, AgriFinTech, deep ...
- Trump tariffs hit patented drugs: Jefferies, Nomura explain impact on pharma stocksThe US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...
- China pulls ahead in biologics race, forcing Indian drugmakers to rethink strategyIndia's drug companies face a tough race in the global biologics market. China is quickly becoming a leader in biotech supply chains. India...
- China+1 strategy gains momentum in pharma, but full monetisation still 2-3 years away: Goldman SachsIndian pharmaceutical and biotech sectors are experiencing early benefits from the global shift away from China, driven by the China+1 stra...
- Marion cough syrup not sold in any other country: WHOOn Wednesday, the UN health agency had said that Noida-based Marion Biotech's cough syrups AMBRONOL and DOK-1 Max are "substandard", and wa...
- Bharat Biotech says supply chains not impacted by Russia-Ukraine conflictIndian vaccine maker Bharat Biotech said on Friday that the Russia-Ukraine conflict had not impacted the company's supply chains so far.
- Small hospitals team up to place bulk vaccine ordersGirdhar Gyani, director general of AHPI, said the vaccine makers will get back with the details on how much they can supply within this wee...
Load More
